Skip to main content
Equibles

Penbrook Management LLC

Position in MESO — Mesoblast Ltd

CIK 1381055 NEW YORK, NY
Back to MESO Full portfolio

Position in MESO

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$1,178,124
-$161,089 QoQ
Shares Held
87,075
0.0% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#9
of 72 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Penbrook Management LLC holds $4,585,431 across 4 Biotechnology names. MESO ranks #2 (25.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRTA
Prothena Corp Public Ltd Co
 271,720 $2,660,138
2 MESO
Mesoblast Ltd
This page 		87,075 $1,178,124
3 REGN
Regeneron Pharmaceuticals, Inc.
 785 $489,478
4 IOVA
Iovance Biotherapeutics, Inc.
 61,945 $257,691

All Filings in MESO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,178,124 87,075
2026-03-31 $1,339,213 87,075
2025-12-31 $1,579,853 87,575
2025-09-30 $1,412,444 87,675
2025-06-30 $954,780 87,675
2025-03-31 $1,094,184 87,675
2024-12-31 $1,803,285 91,075
2024-09-30 $876,436 107,275
2024-06-30 $850,739 124,925
2024-03-31 $627,126 125,175
2023-12-31 $302,885 275,350
2023-09-30 $350,980 285,350
2023-06-30 $999,591 255,650
2023-03-31 $841,088 255,650
2022-12-31 $743,941 255,650
2022-09-30 $651,907 255,650
2022-06-30 $567,543 255,650
2022-03-31 $1,079,687 255,850
2021-12-31 $1,228,080 255,850
2021-09-30 $1,481,164 246,450
2021-06-30 $1,856,162 248,150
2021-03-31 $2,038,141 246,450
2020-12-31 $2,101,699 247,550
2020-09-30 $4,607,531 247,850
2020-06-30 $2,591,225 227,500
2020-03-31 $1,002,144 228,800